Is Eupraxia Pharmaceuticals Inc. (EPRX) a Buy, Sell, or Hold?
NASDAQ : EPRX
Eupraxia Pharmaceuticals Inc. — Institutional Ownership
$6.48 USD
-$0.04 (-0.61%)
- Volume
- 96.25K
- Average Volume
- 300.93K
- Market Capitalization
- $216.95M
- P/E Ratio
- -6.17
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $9.32
- Year Low
- $5.04
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.30
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-12 | Manchester Management Company, LLC | 3.83M | 7.40% |
| 2026-02-17 | MANCHESTER MANAGEMENT COMPANY, LLC | 4.72M | 8.80% |
| 2025-11-14 | Beutel, Goodman & Co Ltd. | 4.06M | 8.00% |
| 2025-11-14 | Robert Disbrow | 3.57M | 7.00% |
| 2025-11-13 | MANCHESTER MANAGEMENT COMPANY, LLC | 5.56M | 10.40% |
| 2024-11-14 | Robert Disbrow | 3.09M | 8.60% |
| 2024-11-07 | Joseph S. Freedman | 4.84M | 12.40% |
EPRX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $7.55 | 39.96M | $301.67M | $80.56M | $154.36K | $221.26M |
| 2024-12-31 | $3.17 | 33.93M | $107.56M | $33.1M | $71859 | $74.53M |
| 2023-12-31 | $2.95 | 24.15M | $71.23M | $14.56M | $7.87M | $64.54M |
| 2022-12-31 | $3.99 | 19.29M | $77.04M | $24.73M | $12.17M | $64.48M |
| 2021-12-31 | $3.73 | 14.24M | $53.11M | $20.89M | $9.99M | $42.21M |
| 2020-12-31 | $3.76 | 12.87M | $48.41M | $150.13K | $12.77M | $61.03M |
| 2019-12-31 | $3.83 | 12.87M | $49.24M | $1.16M | $11.94M | $60.03M |
| 2018-12-31 | $4.03 | 12.87M | $51.79M | $823.48K | $3.79M | $54.76M |
| 2017-12-31 | $3.71 | 12.87M | $47.75M | $4.05M | $12474 | $43.71M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7.24 | 56.71M | $410.6M | $58.5M | $2.01M | $354.11M |
| 2025-12-31 | $7.55 | 51.94M | $392.14M | $80.56M | $154.36K | $311.73M |
| 2025-09-30 | $5.90 | 33.48M | $197.53M | $88.96M | $170.6K | $108.74M |
| 2025-06-30 | $5.76 | 35.91M | $206.86M | $19.77M | $35065 | $187.12M |
| 2025-03-31 | $3.28 | 35.69M | $117.05M | $27.45M | $52774 | $89.65M |
| 2024-12-31 | $3.17 | 35.62M | $112.92M | $33.1M | $71859 | $79.89M |
| 2024-09-30 | $2.63 | 35.62M | $93.69M | $6.38M | $68565 | $87.37M |
| 2024-06-30 | $2.58 | 35.62M | $91.91M | $17.05M | $3.41M | $78.26M |
| 2024-03-31 | $2.95 | 28.81M | $85M | $26.44M | $7.04M | $65.59M |
| 2023-12-31 | $2.95 | 24.15M | $71.23M | $14.56M | $7.87M | $64.54M |
| 2023-09-30 | $4.01 | 27.31M | $109.38M | $33.21M | $15.41M | $91.58M |
| 2023-06-30 | $3.91 | 22.01M | $85.97M | $19.1M | $11.14M | $78M |